Last reviewed · How we verify
NCT05950568
Quadratus Lumborum Block Type III Versus Type II Versus Transversus Abdominis Plane Block in Cesarean Section
NA trial testing Quadratus lumborum block typen II in Cesarean Section in 60 participants. Completed in 25 June 2023.
25 June 2023
Quick facts
| Lead sponsor | The General Authority for Teaching Hospitals and Institutes |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 24 March 2023 |
| Primary completion | 25 June 2023 |
| Estimated completion | 25 June 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Quadratus lumborum block typen II
- Quadratus lumborum block III
- Transversus abdominis plane block — full drug profile →
Conditions studied
- Cesarean Section — all drugs for Cesarean Section →
- Quadratus Lumborum Block — all drugs for Quadratus Lumborum Block →
- Transversus Abdominis Plane Block — all drugs for Transversus Abdominis Plane Block →
Sponsor
The General Authority for Teaching Hospitals and Institutes
Who can join
Adults 18 to 40, female only, with Cesarean Section or Quadratus Lumborum Block. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Compare the type III and type II quadratus lumborum block (QLB) to transversus abdominis plane block (TAPB) regarding efficacy in CS
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Analgesic Effect of Quadratus Lumborum Block Type III and Type II Versus Lateral Transversus Abdominis Plane Block in Cesarean Section: A Randomized Controlled Multicenter Trial.
Elsayed Elashry H, Abdelbadie M, Ali Elshabacy A, Ali Elmiseery O. · · 2024 · cited 2× · PMID 38737590 · DOI 10.5812/aapm-140464
Verify or expand the search:
- PubMed search for NCT05950568
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cesarean Section
Currently open trials in the same condition.
- NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07499947 — Predicting Spinal Hypotension in Cesarean Section · recruiting
- NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
- NCT07440667 — Restrictive vs Liberal Intraoperative Fluid Strategy and Postoperative Outcomes After Elective Cesarean Section · NA · recruiting
Other The General Authority for Teaching Hospitals and Institutes trials
Trials by the same sponsor.
- NCT07295704 — Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema · recruiting
- NCT07295691 — Autologous Serum Eye Drops in Dry Eye Syndrome · NA · recruiting
- NCT07125794 — Original Denis Brawn Brace Versus Its Modification for Management of Relapsed Idiopathic Clubfoot Following Ponseti Cast · recruiting
- NCT07108712 — Diffusion Magnetic Resonance Imaging (dMRI) in the Early Evaluation of Brain White Matter Diseases · recruiting
- NCT07108725 — Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05950568 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The General Authority for Teaching Hospitals and Institutes
- Last refreshed: 25 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05950568.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing